Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

10/15/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 88% of Doctors Support their Colleagues in Russian Cancer Research Center

Unfortunately, the current situation in the N.N. Blokhin Russian Cancer Research Center with possible numerous resignations of doctors is far from rare.

10/8/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 45% of Doctors Believe Latin Studies Are Necessary

Russian doctors are not only professionals, but also highly erudite people. The vast majority of the respondents in an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors consider it impossible to remove Latin from curriculum or reduce the hours in medical universities. In addition to half-joking reasons, such as “to swear in the presence of strangers” or “to learn Gaudeamus”, the doctors note the importance of “professional community”, “friend / foe criteria”, the need to “soften the diagnosis for relatives”, etc.

10/1/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 46% of Doctors Ready to Work in Medical Offices at Pharmacies if Decent Salaries Provided

In early September, Pharmacy Chain 36.6 announced a new project involving medical offices in pharmacies. These offices will be equipped in accordance with the therapeutic activity license, so that customers will be able to receive qualified medical care. The RNC Pharma analyst company, together with the Doktor Na Rabote (Doctor at Work) social network for doctors, conducted on online survey to find out under what conditions a doctor can consider working in those medical offices.

9/26/2019 Database Update: Pharmaceutical Drug Production in Russia (August 2019)

Between January and August 2019, Russia produced 255.8 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 20.2% higher than that of the same period in 2018. In physical terms, the dynamics are +4.5%, with the production volume of 2.83 bln units. If calculated in minimum dosage units (MDU), the dynamics are +3.5%, with the production volume of 47 bln MDUs.

9/24/2019 Database Update: Import of Veterinary Drugs, Feed Supplements, and APIs to Russia (July 2019)

Between January and July 2019, Russia imported 37.7 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms (rubles) 0.1% lower than that of the same period in 2018. The negative dynamics are only due to the import of feed supplements dropping by 12.4%. However, the import of feed supplements is the leader in the volume of import in monetary terms with 19.2 bln RUB. The dynamics in physical terms (units) are only negative, -2.4%.

9/23/2019 Database Update: API Import to Russia (July 2019)

Between January and July 2019, Russia imported 69.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 26.5% higher than that of the same period in 2018. As earlier, a significant price increase contributed to the high dynamics. In physical terms (tons), the dynamics are +4.5%, with the import volume of 7 thousand tons.

9/20/2019 Pharmaceutical Drug Import to Russia (July 2019)

In July 2019, Russia imported 61.5 bln RUB worth of ready-made pharmaceuticals (free circulation prices, VAT included), which is in monetary terms (rubles) +31.5% higher than that of July 2018 and the highest volume since August 2010. Higher dynamics were witnessed in June 2016. However, the dynamics in physical terms are only +7.3%, with the import volume of 183.3 bln units.

9/13/2019 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Questions that Doctors Would Like to Ask Minister of Health

In anticipation of the direct line with the Minister of Health of Russia Veronika Skvortsova, scheduled for September 13, 2019, the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social network for doctors conducted an online survey to find out which problems the professional community finds most concerning and which should be addressed to the Minister.

8/27/2019 Ranking of Russian Pharmaceutical Distributors (Q1 – Q2)

It is unlikely that by the end of this year the pharmaceutical wholesale will have seen any significant achievements or failures. As of yet, the market is only developing in terms of public procurement. The public procurement segment has always been a very specific area, with a limited circle of players and its own rules, which are also very vaguely worded. For example, that massive breakdown in trading due to difficulties in setting the initial maximum price of the contract.

8/20/2019 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (June 2019)

Between January and June 2019, Russia imported 319.8 thousand units, 8.2 bln RUB worth of pharmaceuticals for clinical trials (CT) (free circulation prices), which is in physical terms (units) 15.8% lower and in monetary terms (rubles) 1.4% lower than that of the same period in 2018. While the negative dynamics in physical terms have been registered at least thrice since 2013, the negative dynamics in monetary terms have been registered for the first time.